Insomnia is a clinical sleep disorder characterized by persistent difficulty initiating sleep, maintaining sleep, or waking too early, accompanied by daytime impairment. It may be acute or chronic and is often associated with stress, psychiatric conditions, medical illness, or nervous system hyperarousal. Cognitive Behavioral Therapy for Insomnia (CBT-I) remains the first-line treatment. Non-pharmacological approaches that support autonomic regulation may serve as adjunctive tools. This article is for educational purposes and does not replace individualized medical advice.

What Is Insomnia?

In clinical practice, insomnia is defined not simply by poor sleep, but by:

1. Difficulty falling asleep, staying asleep, or early morning awakening

2. Occurrence at least three nights per week

3. Daytime consequences such as fatigue, reduced concentration, irritability, or impaired performance

Epidemiological data suggest that up to one-third of adults report insomnia symptoms, while approximately 10–15% meet diagnostic criteria for chronic insomnia disorder.

Importantly, insomnia is not merely a nighttime problem. It is a 24-hour disorder involving dysregulation of arousal systems.

The Neurobiology of Insomnia

Modern sleep medicine increasingly understands insomnia as a disorder of hyperarousal.

Patients with insomnia often exhibit:

• Elevated sympathetic nervous system activity

• Increased heart rate variability imbalance

• Higher metabolic rate at night

• Increased cortical activation on EEG

Bonnet & Arand (2010) described insomnia as a state of persistent physiological activation. Rather than an inability to sleep, many patients demonstrate difficulty “deactivating” wake-promoting systems.

The autonomic nervous system plays a central role:

• The sympathetic system promotes alertness and vigilance.

• The parasympathetic system promotes rest and recovery.

In chronic insomnia, sympathetic dominance may persist into the night, preventing normal sleep initiation and consolidation.

Clinical Subtypes of Insomnia

1. Sleep-Onset Insomnia

Patients report prolonged sleep latency—often exceeding 30 minutes.

Common contributors include:

• Stress and anticipatory anxiety

• Rumination or cognitive hyperactivity

• Evening exposure to stimulating media

• Inconsistent sleep timing

These individuals frequently describe “a tired body but an alert mind.”

2. Sleep Maintenance Insomnia

Characterized by recurrent nighttime awakenings and difficulty returning to sleep.

Contributing factors may include:

• Chronic pain conditions

• Obstructive sleep apnea

• Restless legs syndrome

• Depression

• Medication side effects

In older adults, fragmented sleep is particularly prevalent (Foley et al., 1995).

3. Early Morning Awakening

This presentation involves waking earlier than desired with inability to resume sleep.

It is strongly associated with mood disorders, particularly major depressive disorder (Tsuno et al., 2005).

Clinically, this subtype often warrants evaluation for underlying psychiatric conditions.

4. Acute Insomnia

Acute insomnia typically arises in response to identifiable stressors:

• Travel

• Illness

• Occupational stress

• Emotional events

It may resolve spontaneously when the stressor subsides. However, maladaptive coping behaviors—such as extended time in bed or irregular schedules—can perpetuate symptoms.

5. Chronic Insomnia Disorder

Chronic insomnia persists for three months or longer.

Over time, conditioned arousal may develop:

• The bed becomes associated with frustration

• Anticipatory anxiety increases

• Sleep effort paradoxically worsens insomnia

CBT-I directly targets these learned associations and remains the gold standard treatment (Edinger & Means, 2005).

Evidence-Based Treatment Approaches

1. Cognitive Behavioral Therapy for Insomnia (CBT-I)

CBT-I addresses both behavioral and cognitive contributors to insomnia.

Core components include:

• Stimulus control therapy

• Sleep restriction therapy

• Cognitive restructuring

• Relaxation techniques

Meta-analyses confirm durable benefits beyond pharmacotherapy (Trauer et al., 2015).

As a clinician, I consider CBT-I the first-line intervention for chronic insomnia.

2. Sleep Hygiene

While often recommended, sleep hygiene alone is rarely sufficient for chronic insomnia. However, it provides essential baseline structure:

• Regular sleep-wake schedule

• Reduced evening light exposure

• Avoidance of caffeine and alcohol before bedtime

• Comfortable sleep environment

Sleep hygiene should be considered foundational rather than curative.

3. Pharmacologic Therapy

Sedative-hypnotics may reduce sleep latency and increase total sleep time in the short term.

However, risks include:

• Tolerance

• Dependence

• Cognitive impairment

• Rebound insomnia

Medication is typically reserved for short-term use or specific clinical situations.

Emerging Adjunctive Approaches: Autonomic Regulation

Given the role of hyperarousal in insomnia, interventions targeting autonomic balance are of increasing interest.

These include:

• Slow diaphragmatic breathing

• Mindfulness-based stress reduction

• Progressive muscle relaxation

• Transcutaneous auricular vagus nerve stimulation (taVNS)

Preliminary studies suggest that taVNS may enhance parasympathetic activity and reduce sympathetic tone (Tu et al., 2018).

From a clinical standpoint, these methods may serve as supportive tools—particularly for patients whose insomnia is stress-related.

Some wellness devices integrate gentle vagus nerve stimulation principles with breathing guidance and calming auditory input. Products such as DreamPhones fall into this category. They are not medical treatments for insomnia but may support pre-sleep relaxation in individuals experiencing stress-related sleep difficulties.

When Should a Patient Seek Medical Evaluation?

Professional evaluation is recommended if:

• Insomnia persists longer than three months

• There is significant daytime impairment

• Symptoms of depression or anxiety are present

• Loud snoring or breathing interruptions occur

• Unexplained limb movements disturb sleep

Insomnia may be primary, but it may also be secondary to other sleep disorders or medical conditions.

Prevention and Long-Term Sleep Health

Long-term management focuses on:

• Stress management

• Consistent circadian rhythm

• Avoidance of compensatory sleep behaviors

• Early intervention during acute insomnia

Addressing insomnia early reduces the likelihood of chronicity.

Final Clinical Perspective

Insomnia is a multifactorial disorder involving behavioral, psychological, and neurophysiological components.

CBT-I remains the cornerstone of treatment. Pharmacotherapy may have a role in select cases. Autonomic-regulation strategies represent a growing area of interest, particularly for stress-related sleep disturbances.

Effective management requires individualized assessment and a comprehensive approach.

Scientific Review

This article was reviewed by Robert Desimone, Director of the McGovern Institute for Brain Research at MIT, Professor of Neuroscience, and Member of the U.S. National Academy of Sciences.

Dr. Desimone’s research spans attention mechanisms, visual neuroscience, inter-regional brain coordination, and neural oscillations. His work has advanced understanding of how neural signaling influences autonomic regulation, including heart rate modulation and the brain’s natural calming responses.

参考

• Riemann, D. 等 (2015)。失眠的诊断、治疗和管理。《柳叶刀精神病学》。

• Bonnet, MH 和 Arand, DL (2010)。过度唤醒和失眠。《睡眠》。

• Foley, D. 等 (1995)。老年人的睡眠问题。《睡眠》。

• Levenson, JC 等 (2015)。失眠的病理生理学。睡眠医学诊所。

• Edinger, JD 和 Means, MK (2005)。失眠的认知行为疗法。《睡眠》。

• Trauer, JM 等 (2015)。认知行为疗法治疗慢性失眠：系统评价和荟萃分析。《内科年鉴》。

• Holbrook, AM 等 (2000)。苯二氮卓类药物治疗失眠的荟萃分析。CMAJ。

• Tu, Y. 等 (2018)。经皮耳迷走神经刺激作为治疗失眠症的新方法。神经科学前沿。